BMI View: Angola’s economy is booming, making progress in diversifying its economy from its oil-base. Increased foreign investment in natural resources is bringing with it increased demand for healthcare services – as such, we forecast that the pharmaceuticals and healthcare markets will outperform the economy as a whole. But investment in healthcare is held back by many factors. Counterfeit and substandard drugs are a continual problem, and while the basic drugs produced by state-owned Nova Angomédica will go some way to reducing Angola’s reliance on imports, the state still needs to improve its import controls and drug distribution network. Part …
Order / Buy a copy of this report @ http://www.rnrmarketresearch.com/contacts/purchase?rname=111924.
Complete report details with Table of Contents and more @ http://www.rnrmarketresearch.com/angola-pharmaceuticals-and-healthcare-report-q4-2013-market-report.html.
No comments:
Post a Comment